US FDA pregnancy category C : Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
20 окт. 2016 г. · Pregnant women can and should receive a category C drug when the possible benefits of using the drug are more likely than the possible risk of ... |
15 сент. 2022 г. · Oral oseltamivir, zanamivir, and peramivir are "Pregnancy Category C" medications, indicating that controlled clinical studies have not been ... |
Multiple investigations have demonstrated higher rates of pre-term birth and compromised fetal growth among women suffering from influenza in pregnancy. |
Oseltamivir is a Pregnancy Category C drug and is suggested for use in pregnant women with suspected or confirmed influenza, if the potential benefits ... |
16 окт. 2018 г. · The following mutually exclusive categories of oseltamivir exposure during pregnancy were defined: exposure during the first trimester ... |
16 янв. 2024 г. · Although both drugs are classified as B1 (limited data indicating safety in pregnancy), use in pregnant women to date (mostly in second and ... |
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk. B: May be acceptable. Either animal studies show no risk but human ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |